Limited access safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2016-06, Vol.141, p.4-5
Main Authors: Westin, S.N, Sill, M, Coleman, R.L, Waggoner, S.E, Moore, K.N, Mathews, C.A, Jain, A, Modesitt, S.C, Schilder, R, Aghajanian, C
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Obstetrics and Gynecology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2016.04.038